Cancer in Young Adults With Ischemic Stroke

Slides:

Advertisements

Similar presentations

Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.

Advertisements

SORVEGLIANZA DELLE MALATTIE NEOPLASTICHE. Cancer statistics, 2013 CA: A Cancer Journal for Clinicians Volume 63, Issue 1, pages 11-30, 17 JAN 2013 DOI:

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.

by J. Masjuan, M. Barón, M. Lousa, and J. M. Gobernado

Copyright © 2015 by the American Osteopathic Association.

Copyright © 2006 American Medical Association. All rights reserved.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Volume 118, Issue 5, Pages (May 2000)

Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery.

by Youngjin Han, Hojong Park, Sun U

Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction by Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín,

Circ Cardiovasc Interv

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Circ Cardiovasc Interv

Arterioscler Thromb Vasc Biol

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Oxygen Therapy in Ischemic Stroke

Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke by Masahiro Kamouchi, Takayuki Matsuki, Jun Hata, Takahiro.

Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,

by Jenny K. Rinehart, Rena D. Singleton, John C. Adair, Joseph R

Effects of Stroke Localization on Cardiac Autonomic Balance and Sudden Death by Sadberk Lale Tokgözoglu, Mustafa Kemal Batur, Mehmet Akif Topçuoglu, Okay.

Risk of Recurrent Stroke in Patients With Silent Brain Infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) Imaging Substudy.

Peak C-Reactive Protein Level Predicts Long-Term Outcomes in Type B Acute Aortic Dissection by Kenichi Sakakura, Norifumi Kubo, Junya Ako, Hiroshi Wada,

by Mario Di Napoli, Adrian R. Parry-Jones, Craig J. Smith, Stephen J

Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke by Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Yu-Chun Chen, Tzeng-Ji.

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Behavior and Biology: The Basic Sciences for AHA Action

Takotsubo-Like Myocardial Dysfunction in Ischemic Stroke

Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction by Suzanne V. Arnold,

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Contribution of Stroke to the Cochrane Stroke Group Trials Register

New Frontiers in Cardiology

Virtual Reality in Stroke Rehabilitation

Statin Treatment and Functional Outcome After Ischemic Stroke

by Beverly G. Windham, Michael E

Circ Cardiovasc Qual Outcomes

Reflux Esophagitis and the Risk of Stroke in Young Adults

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke by Valérie Wolff, Boris Aleil, Maurice Giroud, Jean-Louis Lorenzini,

by Anuj Shah, Anand Shewale, Corey J. Hayes, and Bradley C. Martin

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

by Clarisse Toledo, George Thomas, Jesse D

The Process of Rehabilitation and Discharge Planning in Stroke

Pulse Pressure and Resistance Artery Structure in the Elderly

by Kamyar Kalantar-Zadeh, Ryan D. Kilpatrick, Charles J

Volume 130, Issue 6, Pages (May 2006)

Volume 119, Issue 4, Pages (October 2000)

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 119, Issue 4, Pages (October 2000)

Cardiovascular Disease and CKD: Core Curriculum 2010

Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort Marlies.

Baseline Characteristics by hs-CRP

Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Kaplan-Meier survival estimates for major cardiovascular events.

BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits

The Journal of Thoracic and Cardiovascular Surgery

CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.

Somatic mutational rates and survival analysis of IBD-CRC.

Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.

Chapter 77 Cervical Cancer: Burden of Disease

Expression of TGFβ ligands in GBM

Jenna Barton, MSN, RN-C, PCCN

Presentation transcript:

Cancer in Young Adults With Ischemic Stroke by Karoliina Aarnio, Heikki Joensuu, Elena Haapaniemi, Susanna Melkas, Markku Kaste, Turgut Tatlisumak, and Jukka Putaala Stroke Volume 46(6):1601-1606 May 22, 2015 Copyright © American Heart Association, Inc. All rights reserved.

Kaplan–Meier estimates of the cumulative risk of death for ischemic stroke patients with and without cancer (A), with no cancer, prestroke cancer, and poststroke cancer (B). Kaplan–Meier estimates of the cumulative risk of death for ischemic stroke patients with and without cancer (A), with no cancer, prestroke cancer, and poststroke cancer (B). Log-rank test P values are provided. POSSC indicates poststroke cancer; and PRESC, prestroke cancer. Karoliina Aarnio et al. Stroke. 2015;46:1601-1606 Copyright © American Heart Association, Inc. All rights reserved.